Your search returned 5 results.

Results
	1.	Anti-PD-L1 Treatment Induced Central Diabetes Insipidus. MedStar authors: Kommalapati, Anuhya PMID: 29220526 Year: 2018 Citation: Journal of Clinical Endocrinology & Metabolism. 103(2):365-369, 2018 02 01. Institution: MedStar Washington Hospital Center Department: Medicine/Internal Medcine Medline publication type: Journal Article Form of publication: Journal Article All authors: Brownell I, Del Rivero J, Ebenuwa I, Gulley J, Kommalapati A, Strauss J, Tella SH, Zhao C DOI: https://dx.doi.org/10.1210/jc.2017-01905 Add to cart (remove)
	2.	Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors: Rao, Suman PMID: 30620668 Year: 2019 Citation: Journal of Clinical Oncology. 37(7):537-546, 2019 03 01. Institution: Medstar Franklin Square Medical Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J DOI: https://dx.doi.org/10.1200/JCO.18.00149 Add to cart (remove)
	3.	Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report. MedStar authors: Cardis, Michael A PMID: 31164102 Year: 2019 Citation: BMC Cancer. 19(1):539, 2019 Jun 04. Institution: MedStar Washington Hospital Center Department: Dermatology Medline publication type: Journal Article Form of publication: Journal Article All authors: Brownell I, Cardis MA, Gulley JL, Jiang H, Strauss J DOI: https://dx.doi.org/10.1186/s12885-019-5759-1 Add to cart (remove)
	4.	Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. MedStar authors: Priebat, Dennis A PMID: 31900276 Year: 2020 Citation: Clinical Cancer Research. 26(6):1258-1266, 2020 03 15. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Attia S, Bolejack V, Burgess M, Davis LE, Hu J, Keung EZ, Lazar AJ, Movva S, Okuno S, Parra Cuentas E, Priebat DA, Reed DR, Reinke DK, Reuben A, Riedel RF, Rodrigues-Canales J, Roland CL, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wang WL, Wargo JA DOI: https://dx.doi.org/10.1158/1078-0432.CCR-19-1824 Add to cart (remove)
	5.	IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer. MedStar authors: Swain, Sandra M MedStar Health PMID: 38755096 Year: 2024 Citation: Annals of Oncology. 35(7):630-642, 2024 Jul. Department: Associate Dean for Research Development Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Form of publication: Journal Article All authors: Dent R, Andre F, Goncalves A, Martin M, Schmid P, Schutz F, Kummel S, Swain SM, Bilici A, Loirat D, Villalobos Valencia R, Im SA, Park YH, De Laurentis M, Colleoni M, Guarneri V, Bianchini G, Li H, Kirchmayer Machackova Z, Mouta J, Deurloo R, Gan X, Fan M, Mani A, Swat A, Cortes J DOI: https://dx.doi.org/10.1016/j.annonc.2024.04.001 Add to cart (remove)

Powered by Koha